Brief: India's Mangalam Drugs And Organics Posts Sept-Quarter Net Loss
Nov 8 (Reuters) - Mangalam Drugs and Organics Ltd
MADR.NS :
* INDIA'S MANGALAM DRUGS AND ORGANICS SEPT-QUARTER NET LOSS
35.6
MILLION RUPEES VERSUS PROFIT 22.3 MILLION RUPEES
* MANGALAM DRUGS AND ORGANICS SEPT-QUARTER NET SALES FROM
OPERATIONS 813.7 MILLION RUPEES VERSUS 1.08 BILLION RUPEES
Source text for Eikon: ID:nBSE9wg0mg
Further company coverage: MADR.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mangalam Drugs and Organics
See all newsBrief: Mangalam Drugs And Organics Ltd Defaulted On Loan Obligations To Bank Of Baroda And Bank Of Maharashtra
Brief: Mangalam Drugs And Organics Defaults On Loans Obligations To Bank Of Baroda And Bank Of Maharashtra Over 30 Days
Brief: Mangalam Drugs And Organics Defaults On Loan Obligations To Bank Of Baroda, Bank Of Maharashtra
Brief: Mangalam Drugs And Organics Names Jeevan M. Dalvi As CFO
Brief: Mangalam Drugs And Organics Gets Order Worth 150 Million Rupees